TY - JOUR T1 - Prevalence and predictors of colonoscopic findings in patients with autoimmune gastritis JF - Journal of Investigative Medicine JO - J Investig Med SP - 73 LP - 78 DO - 10.1136/jim-2021-001911 VL - 70 IS - 1 AU - Emra Asfuroglu Kalkan AU - Cagdas Kalkan AU - Mesut Gumussoy AU - Ozge Gucbey AU - Irfan Soykan Y1 - 2022/01/01 UR - http://hw-f5-jim.highwire.org/content/70/1/73.abstract N2 - The clinical spectrum of autoimmune gastritis is silent in the early stages of the disease and no specific symptom is related to this entity. Although gastroscopic findings of this entity are well defined, data regarding colonoscopic findings are limited. The aims of this study were to determine the prevalence of colonoscopic findings and to explore factors that might affect these findings. This is a retrospective chart review of patients with autoimmune gastritis (n=240). Data regarding colonoscopic findings, serum gastrin and chromogranin A (CgA) levels and gastric histopathological results were extracted and compared with 550 patients positive for Helicobacter pylori and gastric atrophy. Control subjects had colonoscopy and gastroscopy with biopsies. Colorectal lesions were observed in 64 (26.6%) of patients with autoimmune gastritis and 36 (6.6%) patients had colorectal lesions in the control group (p<0.001). Serum gastrin (OR: 8.59, 95% CI 1.72 to 25.07, p<0.001) and CgA levels (OR: 6.79, 95% CI 0.41 to 27.26, p<0.001) were found as factors affecting the presence of colorectal carcinoma. Serum gastrin and CgA levels were also found as predictors for the presence of colorectal adenomas. There is a higher prevalence of colorectal neoplastic lesions in patients with autoimmune gastritis. Serum gastrin and CgA levels were found to be determinants of colorectal neoplastic lesions observed in patients. In the workup of these patients, serum gastrin and CgA levels may guide physicians for the demonstration of colorectal neoplastic lesions.All data relevant to the study are included in the article or uploaded as supplementary information. ER -